Previous close | 84.45 |
Open | 84.15 |
Bid | 82.61 x 900 |
Ask | 85.99 x 800 |
Day's range | 82.92 - 85.05 |
52-week range | 51.51 - 92.08 |
Volume | 2,107,297 |
Avg. volume | 2,481,081 |
Market cap | 52.441B |
Beta (5Y monthly) | 1.02 |
PE ratio (TTM) | 64.59 |
EPS (TTM) | 1.30 |
Earnings date | 21 Apr 2021 - 26 Apr 2021 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 94.25 |
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'll want to...
Edwards Lifesciences (NYSE: EW) today announced new data from the COMMENCE clinical trial that demonstrate Edwards' bioprosthetic surgical aortic valve with the company's novel RESILIA tissue platform show favorable safety and hemodynamic performance through a median of five years follow-up. The data were presented at the 57th annual meeting of the Society of Thoracic Surgeons.
Last week, you might have seen that Edwards Lifesciences Corporation ( NYSE:EW ) released its annual result to the...